Efficacy and safety of extended -release versus standard -release tacrolimus in liver transplant recipients:A systematic review

Wei-long SHI,Hui-lin TANG,Yong-fang HU
DOI: https://doi.org/10.13699/j.cnki.1001-6821.2014.08.022
2014-01-01
Abstract:Objective To systematically assess the efficacy and safety of extended-release versus standard -release tacrolimus in liver transplant recipients.Methods Searched Pubmed , CNKI and other databases in both English and Chinese , researched published randomized controlled trials( RCT) focused on extended -release versus standard -release ta-crolimus in the liver transplant recipients.Meta-analysis was conducted by Revman 5.2 software.Results A total of 4 RCTs were included ,in-volving 797 adult liver transplant recipients.The results of Meta-analy-sis revealed that:no significant differences between the extended -release group and the standard -release group in both efficacy and safety was shown.But the incidence of hyperglycemia in the extended -release group was significantly lower than that of the standard -release group ( P<0.05 ).Conclusion Compared to the standard -release tacroli-musinthelivertransplant recipients , extended -release tacrolimus are e-qually effective for preventing and treating the acute rejection and impro-ving outcomes .And they are almost equally safe except the lower inci-dence of hyperglycemia for the extended -release tacrolimus.
What problem does this paper attempt to address?